Dexcom G7 Continuous Glucose Monitoring System
FDA 510(k) clearance K234133 · decided 2024-02-26
Clearance details
- K-number
- K234133
- Device name
- Dexcom G7 Continuous Glucose Monitoring System
- Applicant
- Dexcom, Inc.
- Decision
- Substantially Equivalent
- Date received
- 2023-12-29
- Decision date
- 2024-02-26
- Days to decision
- 59 days
- Clearance type
- Traditional
- Product code
- QBJ
- Device class
- 2
- Regulation number
- 862.1355
- Medical specialty
- Clinical Chemistry
- Advisory committee
- Clinical Chemistry
- Location
- San Diego, CA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Dexcom
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
Recalls involving this device
No recalls on record reference this clearance.
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| G5 Mobile Continuous Glucose Monitoring System, G6 Continuous Glucose Monitoring System, G7 Continuous Glucose Monitorin (P120005/S091) | Dexcom, Inc. | 2024-01-09 |
| DEXCOM G5 Mobile Continuous Glucose Monitoring System (P120005/S090) | Dexcom, Inc. | 2023-01-12 |
| Dexcom G5 Mobile Continuous Glucose Monitoring System (P120005/S088) | Dexcom, Inc. | 2022-01-20 |
| G5 Mobile Continuous Glucose Monitoring System (P120005/S089) | Dexcom, Inc. | 2021-12-21 |
| G5 Mobile Continuous Glucose Monitoring System (P120005/S087) | Dexcom, Inc. | 2020-09-03 |
| Dexcom G5 Mobile Continuous Glucose Monitoring System (P120005/S086) | Dexcom, Inc. | 2020-01-08 |
| DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM (P120005/S083) | Dexcom, Inc. | 2019-11-01 |
| Dexcom G4 PLATINUM Continuous Glucose Monitoring System, Dexcom G5 Mobile Continuous Glucose Monitoring System (P120005/S082) | Dexcom, Inc. | 2019-08-20 |